AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE
Authors: CHEUNG NKV KUSHNER BH CHEUNG IY KRAMER K CANETE A GERALD W BONILLA MA FINN R YEH SJ LARSON SM
Citation: Nkv. Cheung et al., ANTI-GD(2) ANTIBODY TREATMENT OF MINIMAL RESIDUAL STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE, Journal of clinical oncology, 16(9), 1998, pp. 3053-3060
TAENIA-CRASSICEPS CYSTICERCOSIS - HUMORAL IMMUNE-RESPONSE AND PROTECTION ELICITED BY DNA IMMUNIZATION
Authors: ROSAS G CRUZREVILLA C FRAGOSO G LOPEZCASILLAS F PEREZ A BONILLA MA ROSALES R SCIUTTO E
Citation: G. Rosas et al., TAENIA-CRASSICEPS CYSTICERCOSIS - HUMORAL IMMUNE-RESPONSE AND PROTECTION ELICITED BY DNA IMMUNIZATION, The Journal of parasitology, 84(3), 1998, pp. 516-523
SURVIVAL FROM NON-STAGE-4 NEUROBLASTOMA WITHOUT CYTOTOXIC THERAPY - AN ANALYSIS OF CLINICAL AND BIOLOGICAL MARKERS
Authors: CHEUNG NKV KUSHNER BH LAQUAGLIA MP KRAMER K AMBROS P AMBROS I LADANYI M EDDY J BONILLA MA GERALD W
Citation: Nkv. Cheung et al., SURVIVAL FROM NON-STAGE-4 NEUROBLASTOMA WITHOUT CYTOTOXIC THERAPY - AN ANALYSIS OF CLINICAL AND BIOLOGICAL MARKERS, European journal of cancer, 33(12), 1997, pp. 2117-2120
MUTATIONS IN THE GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR GENE IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA
Authors: DONG F DALE DC BONILLA MA FREEDMAN M FASTH A NEIJENS HJ PALMBLAD J BRIARS GL CARLSSON G VEERMAN AJP WELTE K LOWENBERG B TOUW IP
Citation: F. Dong et al., MUTATIONS IN THE GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR GENE IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA, Leukemia, 11(1), 1997, pp. 120-125
REPORT ON PATIENTS WITH SHWACHMAN-DIAMOND-SYNDROME WITH SEVERE CHRONIC NEUTROPENIA
Authors: BOXER L MORI PG BONILLA MA DALE D CHAM B KINSEY S WELTE K FIER C CATALANO P COTTLE T KANNOURAKIS G FREEDMAN M
Citation: L. Boxer et al., REPORT ON PATIENTS WITH SHWACHMAN-DIAMOND-SYNDROME WITH SEVERE CHRONIC NEUTROPENIA, Blood, 90(10), 1997, pp. 3544-3544
LONG-TERM TREATMENT OF CHRONIC IDIOPATHIC NEUTROPENIA WITH G-CSF
Authors: DALE DC COTTLE T BOLYARD AA FIER C AITCHISON R BONILLA MA BOXER L CATALANO P CHAM B FREEDMAN M KANNOURAKIS G KINSEY S MORI P ZEIDLER C WELTE K
Citation: Dc. Dale et al., LONG-TERM TREATMENT OF CHRONIC IDIOPATHIC NEUTROPENIA WITH G-CSF, Blood, 90(10), 1997, pp. 763-763
INTERNATIONAL NEUROBLASTOMA STAGING SYSTEM STAGE-1 NEUROBLASTOMA - A PROSPECTIVE-STUDY AND LITERATURE-REVIEW
Authors: KUSHNER BH CHEUNG NKV LAQUAGLIA MP AMBROS PF AMBROS IM BONILLA MA LADANYI M GERALD WL
Citation: Bh. Kushner et al., INTERNATIONAL NEUROBLASTOMA STAGING SYSTEM STAGE-1 NEUROBLASTOMA - A PROSPECTIVE-STUDY AND LITERATURE-REVIEW, Journal of clinical oncology, 14(7), 1996, pp. 2174-2180
DESMOPLASTIC SMALL ROUND-CELL TUMOR - PROLONGED PROGRESSION-FREE SURVIVAL WITH AGGRESSIVE MULTIMODALITY THERAPY
Authors: KUSHNER BH LAQUAGLIA MP WOLLNER N MEYERS PA LINDSLEY KL GHAVIMI F MERCHANT TE BOULAD F CHEUNG NKV BONILLA MA CROUCH G KELLEHER JF STEINHERZ PG GERALD WL
Citation: Bh. Kushner et al., DESMOPLASTIC SMALL ROUND-CELL TUMOR - PROLONGED PROGRESSION-FREE SURVIVAL WITH AGGRESSIVE MULTIMODALITY THERAPY, Journal of clinical oncology, 14(5), 1996, pp. 1526-1531
SURVIVAL FROM LOCALLY INVASIVE OR WIDESPREAD NEUROBLASTOMA WITHOUT CYTOTOXIC THERAPY
Authors: KUSHNER BH CHEUNG NKV LAQUAGLIA MP AMBROS PF AMBROS IM BONILLA MA GERALD WL LADANYI M GILBERT F ROSENFIELD NS YEH SDJ
Citation: Bh. Kushner et al., SURVIVAL FROM LOCALLY INVASIVE OR WIDESPREAD NEUROBLASTOMA WITHOUT CYTOTOXIC THERAPY, Journal of clinical oncology, 14(2), 1996, pp. 373-381
POPULATION-GENETICS, DIPLOID MALES, AND LIMITS TO SOCIAL EVOLUTION OFEUGLOSSINE BEES
Authors: ROUBIK DW WEIGT LA BONILLA MA
Citation: Dw. Roubik et al., POPULATION-GENETICS, DIPLOID MALES, AND LIMITS TO SOCIAL EVOLUTION OFEUGLOSSINE BEES, Evolution, 50(2), 1996, pp. 931-935
REPORT ON PATIENTS WITH GLYCOGEN-STORAGE-DISEASE 1B WITH SEVERE CHRONIC NEUTROPENIA (SCN) TREATED WITH FILGRASTIM
Authors: KANNOURAKIS G KURTZBERG J BONILLA MA BOXER L CATALANO P CHAM B FIER C KINSEY S MARTY J FREEDMAN MH MORI PG THOMPSON B DALE DC WELTE K
Citation: G. Kannourakis et al., REPORT ON PATIENTS WITH GLYCOGEN-STORAGE-DISEASE 1B WITH SEVERE CHRONIC NEUTROPENIA (SCN) TREATED WITH FILGRASTIM, Blood, 88(10), 1996, pp. 1383-1383
REPORT ON PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN) REFRACTORY TO G-CSF
Authors: ZEIDLER C BONILLA MA BOXER L CATALANO P CHAM B FIER C FREEDMAN MH KANNOURAKIS G KINSEY S MORI PG DALE DC WELTE K
Citation: C. Zeidler et al., REPORT ON PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN) REFRACTORY TO G-CSF, Blood, 88(10), 1996, pp. 1386-1386
MDS AML IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN) RECEIVING G-CSF/
Authors: FREEDMAN MH BONILLA MA BOXER L CATALANO P CHAM B FIER C KANNOURAKIS G KINSEY S MORI PG SHANNON K TOUW I WELTE K DALE DC
Citation: Mh. Freedman et al., MDS AML IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN) RECEIVING G-CSF/, Blood, 88(10), 1996, pp. 1782-1782
CYTOKINE TREATMENT OF SEVERE CHRONIC NEUTROPENIA
Authors: BONILLA MA
Citation: Ma. Bonilla, CYTOKINE TREATMENT OF SEVERE CHRONIC NEUTROPENIA, International journal of pediatric hematology/oncology, 2(2), 1995, pp. 117-124
VERY-HIGH-DOSE SHORT-TERM CHEMOTHERAPY FOR POOR-RISK PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMORS, INCLUDING EWINGS-SARCOMA, IN CHILDREN ANDYOUNG-ADULTS
Authors: KUSHNER BH MEYERS PA GERALD WL HEALEY JH LAQUAGLIA MP BOLAND P WOLLNER N CASPER ES ALEDO A HELLER G SCHWARTZ GK BONILLA MA LINDSLEY KL MERCHANT TE ROSENFIELD NS ABRAMSON SJ CHEUNG NKV
Citation: Bh. Kushner et al., VERY-HIGH-DOSE SHORT-TERM CHEMOTHERAPY FOR POOR-RISK PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMORS, INCLUDING EWINGS-SARCOMA, IN CHILDREN ANDYOUNG-ADULTS, Journal of clinical oncology, 13(11), 1995, pp. 2796-2804
MONOSOMY-7 AND ACTIVATING RAS MUTATIONS ACCOMPANY MALIGNANT TRANSFORMATION IN PATIENTS WITH CONGENITAL NEUTROPENIA
Authors: KALRA R DALE D FREEDMAN M BONILLA MA WEINBLATT M GANSER A BOWMAN P ABISH S PRIEST J OSEAS RS OLSON K PADERANGA D SHANNON K
Citation: R. Kalra et al., MONOSOMY-7 AND ACTIVATING RAS MUTATIONS ACCOMPANY MALIGNANT TRANSFORMATION IN PATIENTS WITH CONGENITAL NEUTROPENIA, Blood, 86(12), 1995, pp. 4579-4586
SEVERE CHRONIC NEUTROPENIA - REPORT ON TREATMENT AND OUTCOME FROM A NEW INTERNATIONAL REGISTRY
Authors: DALE DC COTTLE T BOLYARD AA FIER C BONILLA MA BOXER L BROWN SL CHAM B FREEDMAN M KANNOURAKIS G WELTE K
Citation: Dc. Dale et al., SEVERE CHRONIC NEUTROPENIA - REPORT ON TREATMENT AND OUTCOME FROM A NEW INTERNATIONAL REGISTRY, Blood, 86(10), 1995, pp. 1686-1686
ADMINISTRATION OF R-METHUG-CSF DURING PREGNANCY IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN)
Authors: BOXER L DALE D BONILLA MA CHAM B FREEDMAN M KANNOURAKIS G BROWN S FIER C WELTE K
Citation: L. Boxer et al., ADMINISTRATION OF R-METHUG-CSF DURING PREGNANCY IN PATIENTS WITH SEVERE CHRONIC NEUTROPENIA (SCN), Blood, 86(10), 1995, pp. 2020-2020
CLINICAL-PROGRESS IN NEUROBLASTOMA
Authors: BONILLA MA CHEUNG NKV
Citation: Ma. Bonilla et Nkv. Cheung, CLINICAL-PROGRESS IN NEUROBLASTOMA, Cancer investigation, 12(6), 1994, pp. 644-653
HIGHLY EFFECTIVE INDUCTION THERAPY FOR STAGE-4 NEUROBLASTOMA IN CHILDREN OVER 1 YEAR OF AGE
Authors: KUSHNER BH LAQUAGLIA MP BONILLA MA LINDSLEY K ROSENFIELD N YEH S EDDY J GERALD WL HELLER G CHEUNG NKV
Citation: Bh. Kushner et al., HIGHLY EFFECTIVE INDUCTION THERAPY FOR STAGE-4 NEUROBLASTOMA IN CHILDREN OVER 1 YEAR OF AGE, Journal of clinical oncology, 12(12), 1994, pp. 2607-2613
CORRECTION OF NEUTROPENIA WITH RHUG-CSF AFTER LOSS OF RESPONSE TO RHUGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT
Authors: BOULAD F GILLIO A SMALL TN BONILLA MA PHILIPS P RUGGIERO M EMANUEL D GHAVIMI F KERNAN NA
Citation: F. Boulad et al., CORRECTION OF NEUTROPENIA WITH RHUG-CSF AFTER LOSS OF RESPONSE TO RHUGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANT, Bone marrow transplantation, 13(5), 1994, pp. 661-663
STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE - GROSS TOTAL RESECTION AND CLINICAL OUTCOME
Authors: LAQUAGLIA MP KUSHNER BH HELLER G BONILLA MA LINDSLEY KL CHEUNG NKV
Citation: Mp. Laquaglia et al., STAGE-4 NEUROBLASTOMA DIAGNOSED AT MORE THAN 1 YEAR OF AGE - GROSS TOTAL RESECTION AND CLINICAL OUTCOME, Journal of pediatric surgery, 29(8), 1994, pp. 1162-1166
ANTIBODY-RESPONSE TO MURINE ANTI-G(D2) MONOCLONAL-ANTIBODIES - CORRELATION WITH PATIENT SURVIVAL
Authors: CHEUNG NKV CHEUNG IY CANETE A YEH SJ KUSHNER B BONILLA MA HELLER G LARSON SM
Citation: Nkv. Cheung et al., ANTIBODY-RESPONSE TO MURINE ANTI-G(D2) MONOCLONAL-ANTIBODIES - CORRELATION WITH PATIENT SURVIVAL, Cancer research, 54(8), 1994, pp. 2228-2233
LONG-TERM SAFETY OF TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIAS
Authors: BONILLA MA DALE D ZEIDLER C LAST L REITER A RUGGEIRO M DAVIS M KOCI B HAMMOND W GILLIO A WELTE K
Citation: Ma. Bonilla et al., LONG-TERM SAFETY OF TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF) IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIAS, British Journal of Haematology, 88(4), 1994, pp. 723-730
MONOSOMY 7 AND ACTIVATING RAS MUTATIONS ACCOMPANY MALIGNANT TRANSFORMATION IN PATIENTS WITH CONGENITAL NEUTROPENIA (CN) TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RH-G-CSF)
Authors: KALRA R DALE D FREEDMAN M BONILLA MA WEINBLATT M GANSER A BOWMAN P ABISH S PRIES J OLSON K PADERANGA D SHANNON K
Citation: R. Kalra et al., MONOSOMY 7 AND ACTIVATING RAS MUTATIONS ACCOMPANY MALIGNANT TRANSFORMATION IN PATIENTS WITH CONGENITAL NEUTROPENIA (CN) TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RH-G-CSF), Blood, 84(10), 1994, pp. 10000313-10000313
Risultati: 1-25 | 26-28